Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal3.jpg" NAME"Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ" ALT"Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ"September 6, 2017By…

Continue ReadingTiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ

Verastem Soars as Blood Cancer Drug Succeeds in Phase III Study

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Verastem Soars as Blood Cancer Drug Succeeds in Phase III Study" ALT"Verastem Soars as Blood Cancer Drug Succeeds in Phase III Study"September 6, 2017By Alex Keown, BioSpace.com Breaking…

Continue ReadingVerastem Soars as Blood Cancer Drug Succeeds in Phase III Study

How Gilead and Kite Pharma's Flirtation Became the Real Thing

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x600-deal.jpg" NAME"How Gilead and Kite Pharma's Flirtation Became the Real Thing" ALT"How Gilead and Kite Pharma's Flirtation Became the Real Thing"September 6, 2017By Mark Terry, BioSpace.com Breaking News StaffThe...…

Continue ReadingHow Gilead and Kite Pharma's Flirtation Became the Real Thing